11 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28283335	34	Discovery of selective ATP-competitive eIF4A3 inhibitors.	Takeda Pharmaceutical
23025805	74	Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors.	Infinity Pharmaceuticals
22128783	2	Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies.	Boston University
32470302	25	Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.	Inception Therapeutics
16532013	19	Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A.	Mcgill University
29057054	29	Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1	Takeda Pharmaceutical
28358513	44	Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors.	Takeda Pharmaceutical
28751196	46	Discovery of spiro[indole-3,2'-pyrrolidin]-2(1H)-one based inhibitors targeting Brr2, a core component of the U5 snRNP.	Takeda Pharmaceutical
28586220	27	Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2.	Takeda California
10777579	12	Thermodynamic consequences of grafting enhanced affinity toward the mutated antigen onto an antibody. The case of anti-lysozyme antibody, HyHEL-10.	Tohoku University